Go to Wolters Kluwer VitalLaw.comGo to Wolters Kluwer VitalLaw.com
VitalLaw®
  • Find answers to your questions
  • Log in to access your subscriptions
In depth. On point.
In depth. On point.
  • Home
  • Legal Directory
  • Home
  • Legal Directory
In depth. On point.
  • Articles
  • Articles
  • Law Firms
  • Law Firms
  • Organizations
  • Organizations
    • GENERAL HEALTH CARE NEWS—E.D.N.Y.: Surgery practice’s challenge to No Surprises Act dismissed
    • ADMINISTRATION OF MEDICARE/MEDICAID PROGRAMS—DAB DECISIONS: DMEPOS Supplier had no right to review duration of CMS revocation
    • ADMINISTRATION OF THE FDC ACT—NOTICES: FDA revokes EUAs for multiple COVID-19 tests approved during the COVID-19 pandemic
    • ADVERTISING (FOOD, DRUG & MEDICAL DEVICES)—N.D. Cal.: Class certification denied in consumer protection case over ghee food labels
    • AUDITS AND MONITORING—OIG REPORTS: HHS falls short of full compliance with PIIA for FY 2024
    • CONTROLLED SUBSTANCES—NOTICES: Importer debarred for selling non-FDA approved drugs
    • ELECTRONIC HEALTH RECORDS—SETTLEMENT AGREEMENTS: Medical Record Data Breach Leads to Fine for Health Care Provider
    • EXPERT INSIGHTS: CMS to immediately begin auditing Medicare Advantage plans in significant expansion of enforcement efforts
    • GENERAL HEALTH CARE NEWS—GAO REPORTS: GAO addresses Congress’ concerns regarding caregiving youth issues
    • HEALTH CARE EMPLOYMENT ISSUES—D. Md.: Evidentiary requests denied in COVID-19 vaccine mandate religious discrimination case
    • HEALTH CARE EMPLOYMENT ISSUES—W.D. Va.: Lawsuit alleging COVID-19 vaccine religious discrimination dismissed in part
    • HIPAA—SETTLEMENT AGREEMENTS: OCR settles HIPAA cybersecurity investigation with small health care provider
    • LAW FIRM NEWS—Noteworthy developments in the legal community
    • MISBRANDING (FOOD, DRUGS & MEDICAL DEVICES)—NOTICES: Importer debarred for offering for sale misbranded male enhancement drugs
  • Articles
  • Articles
  • Law Firms
  • Law Firms
  • Organizations
  • Organizations

    Health Law Daily Wrap Up, EXPERT INSIGHTS: CMS to immediately begin auditing Medicare Advantage plans in significant expansion of enforcement efforts, (May 30, 2025)

    Law Firms Mentioned:Proskauer Rose LLP
    Organizations Mentioned:Proskauer Rose, LLP

    By David Manko, Jason Madden, Matthew J. Westbrook, Michael J. Menconi and Vinay Kohli of Proskauer Rose LLP

    CMS plans to use a two-pronged approach to accelerate auditing the backlog it faces.

    On May 21, 2025, the Centers for Medicare and Medicaid Services ("CMS") announced a significant expansion of its auditing efforts with respect to Medicare Advantage ( ...

    By David Manko, Jason Madden, Matthew J. Westbrook, Michael J. Menconi and Vinay Kohli of Proskauer Rose LLP

    CMS plans to use a two-pronged approach to accelerate auditing the backlog it faces.

    On May 21, 2025, the Centers for Medicare and Medicaid Services ("CMS") announced a significant expansion of its auditing efforts with respect to Medicare Advantage ("MA") plans.

    For newly initiated audits of MA plans, CMS will audit all eligible MA contracts for each payment year. Additionally, for audits already initiated, CMS will expedite the completion of audits for payment years ("PYs") 2018 through 2024. While the Trump Administration has expressed frustration at the fact that CMS is currently several years behind in completing these audits, CMS has vowed to shore-up its backlog and complete all audits for PY 2018 to PY 2024 by early 2026.

    CMS verifies the accuracy of risk-adjusted payments to MA plans by conducting Risk Adjustment Data Validation ("RADV") audits, which seek to ensure that any diagnoses submitted by health plans are supported by the patient's medical records. If such diagnoses are unsupported, CMS may seek recoupment of funds paid to those MA health plans based on the unsupported risk adjusted diagnoses.

    CMS has outlined a two-pronged approach in accelerating RADV audits. First, it will use enhanced technology to efficiently review medical records and flag unsupported diagnoses—allowing CMS to drastically increase the number of audits conducted each year. Currently, CMS audits between 50 and 60 health plans per year—CMS expects that such enhanced technology will enable them to enable all 550 active MA health plans each year. Additionally, CMS will increase its auditing sample of each MA health plan from 35 records per health plan per year to 200. Second, CMS will substantially increase the number of medical coders employed to manually verify flagged diagnoses—increasing audit efficiency. CMS notes that it plans to increase its team of medical coders from 40 to approximately 2,000 by September 1, 2025.

    CMS's continued and now-heightened and aggressive focus on RADV audits comes as part of the Trump Administration's intensified efforts to combat waste, fraud and abuse in health care. It is important to note that while CMS may recover overpayments made to MA health plans based on unsupported diagnosis codes, the MA health plans may then seek to recover those amounts from downstream providers. Depending on their contract with the MA health plan, such downstream providers may be scrutinized for causing the MA health plan to submit an unsupported diagnosis code to CMS. Such aggressive enforcement measures from the Trump Administration signals to the industry that it should ensure that the auditing and monitoring component of its compliance program is proactive and not just reactive.

    CMS's most recent final rule on RADV audits, which updated RADV audit methodology with the aim of improving MA program integrity and payment accuracy, became effective on April 3, 2023.

    Proskauer will continue to monitor these developments and their effect on both MA plans and downstream providers.

    View original.

    CMS to Immediately Begin Auditing Medicare Advantage Plans in Significant Expansion of Enforcement Efforts

    The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

    David Manko, Jason Madden, Matthew J. Westbrook, Michael J. Menconi and Vinay

    Kohli

    Proskauer Rose LLP

    Eleven Times Square

    (Eighth Avenue & 41st Street).

    New York

    10036-8299 United States

    Tel.: +1 212 9693000

    E-mail: gpolk@proskauer.com

    URL: www.proskauer.com/

    (c) Mondaq Ltd, 2025 - Tel. +44 (0)20 8544 8300 - http://www.mondaq.com

    Attorneys: David Manko, Jason Madden, Matthew J. Westbrook, Michael J. Menconi and Vinay Kohli (Proskauer Rose LLP).

    ExpertInsights: NewsStory ExpertInsights CMSNews AuditNews EHRNews PartCNews

    © 2026 CCH Incorporated and its affiliates and licensors. All rights reserved.

    • Manage Cookie Preferences
    • Privacy Statement
    • Terms of Use